Naoki Uno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Naoki Uno has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
Katsunori Yanagihara
Department of Laboratory Medicine
11 shared publicationsYoshitomo Morinaga
Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences. Nagasaki 852-8501, Japan
6 shared publications- Hiroo Hasegawa
Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, 852-8501, Japan
5 shared publications - Norihito Kaku
Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
5 shared publications Hiroo Hasegawa
Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences. Nagasaki 852-8501, Japan
4 shared publicationsKosuke Kosai
Department of Laboratory Medicine
4 shared publications
Latest Publications
- 16 June 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
Bioluminescence Assay for Highly Sensitive Detection of Pathogen DNA Directly from PCR Products via Cell-Free Synthesis of a Fragment of NanoLuc Luciferase
Biosensing of nucleic acids by reporter proteins has the potential to outperform traditional fluorophore-based nucleic acid detection systems. However, its complexity and low sensitivity limit utility, particularly in clinical settings. Here, we devised a method that couples PCR amplification to cell-free synthesis of a HiBiT peptide, which is fragment of NanoLuc luciferase. This is achieved by tailing PCR primers with sequences required for in vitro transcription and translation of HiBiT. This method, named HiBiT-PCR, allowed us to generate NanoLuc luciferase directly from the PCR product, with a detection limit for Mycobacterium tuberculosis DNA as low as 1 copy/μL. Furthermore, we validated HiBiT-PCR using clinical samples. The results show that HiBiT-PCR is a highly sensitive and streamlined method for detecting pathogen DNA.
- 16 June 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
Bioluminescence Assay for Highly Sensitive Detection of Pathogen DNA Directly from PCR Products via Cell-Free Synthesis of a Fragment of NanoLuc Luciferase
Biosensing of nucleic acids by reporter proteins has the potential to outperform traditional fluorophore-based nucleic acid detection systems. However, its complexity and low sensitivity limit utility, particularly in clinical settings. Here, we devised a method that couples PCR amplification to cell-free synthesis of a HiBiT peptide, which is fragment of NanoLuc luciferase. This is achieved by tailing PCR primers with sequences required for in vitro transcription and translation of HiBiT. This method, named HiBiT-PCR, allowed us to generate NanoLuc luciferase directly from the PCR product, with a detection limit for Mycobacterium tuberculosis DNA as low as 1 copy/μL. Furthermore, we validated HiBiT-PCR using clinical samples. The results show that HiBiT-PCR is a highly sensitive and streamlined method for detecting pathogen DNA.
- 26 May 2026
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 310, 118860
CRISPR-Cas12a biosensing via transcription of crRNA from PCR or LAMP products for pathogen detection
- 26 May 2026
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 310, 118860
CRISPR-Cas12a biosensing via transcription of crRNA from PCR or LAMP products for pathogen detection
- Open Access
- 20 May 2026
- Published by Springer Nature in Communications Materials
- Vol. 7 (1)
Quantifying neutrophil phagocytes by droplet digital cell PCR for diagnosis of bacteremia
- 20 May 2026
- Published by Springer Nature in Communications Materials
- Vol. 7 (1)
Open AccessQuantifying neutrophil phagocytes by droplet digital cell PCR for diagnosis of bacteremia
- Open Access
- 15 April 2026
- Published by Qeios Ltd
Review of: "Optimization of Pre-Sampling Conditions for Salivary Genomic DNA Extraction: A Single-Donor Analysis"
The study is simple but informative because saliva is an easy-to-collect specimen. The results are limited but instructive from a technical point of view. The authors wrote the protocol in detail and stated the limitations of the study. However, I h...
- 15 April 2026
- Published by Qeios Ltd
Open AccessReview of: "Optimization of Pre-Sampling Conditions for Salivary Genomic DNA Extraction: A Single-Donor Analysis"
The study is simple but informative because saliva is an easy-to-collect specimen. The results are limited but instructive from a technical point of view. The authors wrote the protocol in detail and stated the limitations of the study. However, I h...
- 29 June 2025
- Published by Springer Nature
- p. 81-88
Sex Genotyping by Flow Cytometry
- 24 April 2023
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1262, 341258
CRISPR gel: A one-pot biosensing platform for rapid and sensitive detection of HIV viral RNA
- 24 April 2023
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1262, 341258
CRISPR gel: A one-pot biosensing platform for rapid and sensitive detection of HIV viral RNA
- 10 February 2023
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 17 (4) , 3966-3975
Bioinspired CRISPR-Mediated Cascade Reaction Biosensor for Molecular Detection of HIV Using a Glucose Meter
HIV molecular detection plays a significant role in early diagnosis and antiretroviral therapy for HIV patients. CRISPR technology has recently emerged as a powerful tool for highly sensitive and specific nucleic acid-based molecular detection when used in combination with isothermal amplification. However, it remains a challenge to improve the compatibility of such a multi-enzyme reaction system for simple and sensitive molecular detection. Inspired by the multi-compartment structures in a living cell, we present a nanoporous membrane-separated (compartmentalized), artificial, cascade reaction system to improve the compatibility of a CRISPR-mediated multi-enzyme reaction. We further integrated the multi-enzyme cascade reaction system with a microfluidic platform and glucose biosensing technology to develop a bioinspired, CRISPR-mediated cascade reaction (CRISPR-MCR) biosensor, enabling HIV molecular detection by a simple glucose meter, analogous to diabetes home testing. We applied the bioinspired CRISPR-MCR biosensor to detect HIV DNA and HIV RNA, achieving a detection sensitivity of 43 copies and 200 copies per test, respectively. Further, we successfully validated the bioinspired biosensor by testing clinical plasma samples of HIV, demonstrating its great application potential for point-of-care testing of HIV virus and other pathogens at home or in resource-limited settings.
- 10 February 2023
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 17 (4) , 3966-3975
Bioinspired CRISPR-Mediated Cascade Reaction Biosensor for Molecular Detection of HIV Using a Glucose Meter
HIV molecular detection plays a significant role in early diagnosis and antiretroviral therapy for HIV patients. CRISPR technology has recently emerged as a powerful tool for highly sensitive and specific nucleic acid-based molecular detection when used in combination with isothermal amplification. However, it remains a challenge to improve the compatibility of such a multi-enzyme reaction system for simple and sensitive molecular detection. Inspired by the multi-compartment structures in a living cell, we present a nanoporous membrane-separated (compartmentalized), artificial, cascade reaction system to improve the compatibility of a CRISPR-mediated multi-enzyme reaction. We further integrated the multi-enzyme cascade reaction system with a microfluidic platform and glucose biosensing technology to develop a bioinspired, CRISPR-mediated cascade reaction (CRISPR-MCR) biosensor, enabling HIV molecular detection by a simple glucose meter, analogous to diabetes home testing. We applied the bioinspired CRISPR-MCR biosensor to detect HIV DNA and HIV RNA, achieving a detection sensitivity of 43 copies and 200 copies per test, respectively. Further, we successfully validated the bioinspired biosensor by testing clinical plasma samples of HIV, demonstrating its great application potential for point-of-care testing of HIV virus and other pathogens at home or in resource-limited settings.
- 6 January 2023
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 148 (4) , 926-931
Single-tube one-step gel-based RT-RPA/PCR for highly sensitive molecular detection of HIV
We developed a single-tube one-step gel-based reverse transcription-recombinase polymerase amplification (RT-RPA)/polymerase chain reaction (PCR) (termed “SOG RT-RPA/PCR”) to detect the human immunodeficiency virus (HIV). To improve the assay sensitivity, the RNA template is pre-amplified by RT-RPA prior to PCR. To simplify the detection process and shorten the assay time, we embedded PCR reagents into agarose gel, constructing it to physically separate the reagents from the RT-RPA reaction solution in a single tube. Due to the thermodynamic properties of agarose, the RT-RPA reaction first occurs independently on top of the PCR gel at a low temperature (e.g., 39 °C) during the SOG RT-RPA/PCR assay. Then, the RPA amplicons directly serve as the template for the second PCR amplification reaction, which begins when the PCR agarose dissolves due to the elevated reaction temperature, eliminating the need for multiple manual operations and amplicon transfer. With our SOG RT-RPA/PCR assay, we could detect 6.3 copies of HIV RNA per test, which is a 10-fold higher sensitivity than that of standalone real-time RT-PCR and RT-RPA. In addition, due to the high amplification efficiency of RPA, the SOG RT-RPA/PCR assay shows stronger fluorescence detection signals and a shorter detection time compared to the standalone real-time RT-PCR assay. Furthermore, we detected HIV viral RNA in clinical plasma samples and validated the superior performance of our assay. Thus, the SOG RT-RPA/PCR assay offers a powerful method for simple, rapid, and highly sensitive nucleic acid-based molecular detection of infectious diseases.
- 6 January 2023
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 148 (4) , 926-931
Single-tube one-step gel-based RT-RPA/PCR for highly sensitive molecular detection of HIV
We developed a single-tube one-step gel-based reverse transcription-recombinase polymerase amplification (RT-RPA)/polymerase chain reaction (PCR) (termed “SOG RT-RPA/PCR”) to detect the human immunodeficiency virus (HIV). To improve the assay sensitivity, the RNA template is pre-amplified by RT-RPA prior to PCR. To simplify the detection process and shorten the assay time, we embedded PCR reagents into agarose gel, constructing it to physically separate the reagents from the RT-RPA reaction solution in a single tube. Due to the thermodynamic properties of agarose, the RT-RPA reaction first occurs independently on top of the PCR gel at a low temperature (e.g., 39 °C) during the SOG RT-RPA/PCR assay. Then, the RPA amplicons directly serve as the template for the second PCR amplification reaction, which begins when the PCR agarose dissolves due to the elevated reaction temperature, eliminating the need for multiple manual operations and amplicon transfer. With our SOG RT-RPA/PCR assay, we could detect 6.3 copies of HIV RNA per test, which is a 10-fold higher sensitivity than that of standalone real-time RT-PCR and RT-RPA. In addition, due to the high amplification efficiency of RPA, the SOG RT-RPA/PCR assay shows stronger fluorescence detection signals and a shorter detection time compared to the standalone real-time RT-PCR assay. Furthermore, we detected HIV viral RNA in clinical plasma samples and validated the superior performance of our assay. Thus, the SOG RT-RPA/PCR assay offers a powerful method for simple, rapid, and highly sensitive nucleic acid-based molecular detection of infectious diseases.
- Open Access
- 1 December 2020
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 19, 467-473
A Methodology for Assessing Tumor Clonality of Adult T Cell Leukemia/Lymphoma
- 1 December 2020
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 19, 467-473
Open AccessA Methodology for Assessing Tumor Clonality of Adult T Cell Leukemia/Lymphoma
- 11 November 2020
- Published by Springer Nature
- p. 69-77
Rapid Diagnosis of Influenza Viral Infection: What Are the Rapid Diagnostic Tests and Molecular Diagnosis?
- 11 November 2020
- Published by Springer Nature
- p. 69-77
Rapid Diagnosis of Influenza Viral Infection: What Are the Rapid Diagnostic Tests and Molecular Diagnosis?